Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Comments

Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB

Chun-Yan Li email, Bao-Xiu Li email, Yi Liang email, Rui-Qing Peng email, Ya Ding email, Da-Zhi Xu email, Xin Zhang email, Zhi-Zhong Pan email, De-Sen Wan email, Yi-Xin Zeng email, Xiao-Feng Zhu email and Xiao-Shi Zhang email

Journal of Translational Medicine 2009, 7:56doi:10.1186/1479-5876-7-56

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.